The outcomes of this study showed that the expression of AIFM2 and GPX4 and the GSH/GSSG ratio were upregulated in HER‐2‐positive BC; therefore, HER‐2‐positive BC cells can activate two pathways to inhibit ferroptosis. Here, ERBB2 is linked to breast cancer.